RenovaCare Inc (RCAR)
RenovaCare, Inc. is a development-stage biotechnology and medical device company listed on OTC Markets as common stock. The company focuses on research, development, and commercialization of autologous cellular therapies for medical and aesthetic applications. Its development efforts include the CellMist System, designed for cell isolation to support human skin cell regeneration, and the SkinGun, a sprayer intended to deliver cells to a treatment area. RenovaCare also has a strategic collaboration with StemCell Systems GmbH related to isolating and spraying self-donated stem cells for tissue and organ regeneration. Incorporated in 1983 and based in Scottsdale, Arizona, the company was previously known as Janus Resources, Inc. and adopted the RenovaCare name in 2014.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RCAR
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.087 K
|
—
|
—
|
—
|
—
|
—
|
—
|